TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial September 24, 2010
TCL Archive Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center December 11, 1992